Description
Thymosin Beta-4 Fragment (1-4) (Ac-SDKP) is a synthetic research peptide corresponding to a segment of Thymosin Beta-4, a 43-amino-acid actin-binding protein involved in cytoskeletal organization. Preclinical studies demonstrate that TB-500 modulates actin polymerization, cell migration, and angiogenic signaling, primarily through the β-actin/G-actin regulatory cycle. It is widely studied for its role in tissue modeling, cellular motility, and regeneration mechanisms in controlled laboratory settings.
References:
Goldstein AL et al., Ann NY Acad Sci, 2007 1112:148-154
Huff T et al., J Mol Biol, 2001 312(3): 593-606
Malinda KM et al., FASEB J, 1999 13(14): 2106-2114
These capsules are provided exclusively as inert containers for the dry transport, storage, and handling of laboratory research materials. They are not dosage forms and are not intended for ingestion or administration. They must not be used as drug delivery systems, consumed, or administered in any form. For Research Use Only: Not for use in humans or animals. Not for diagnostic or therapeutic purposes.


Reviews
There are no reviews yet.